Carreño discusses oral protein-folding correction for RHO-adRP, early-phase trial end points and genetic eligibility.
Ester Carreño, MD, PhD
Advertisement
Ester Carreño, MD, PhD, is a consultant ophthalmologist specializing in uveitis at University Hospital La Paz in Madrid, Spain, where she oversees clinical research within the Uveitis and Ocular Inflammation program.
Articles by Ester Carreño, MD, PhD
Ester Carreño, MD, PhD, explains how to tell retinitis pigmentosa from uveitis and why genetic confirmation now matters more.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA requires NAION warning across the GLP-1 receptor agonist class
2
Viridian's VRDN-008 sustains IgG suppression through 8 weeks in phase 1
3
VERONA: Katherine Talcott, MD, on early gains with a TKI insert in DME
4
Tenpoint Therapeutics opens telehealth access to Yuvezzi for adults with presbyopia
5